IMA-1 is a small molecule for the treatment of NASH by interrupting the interaction of arachidonic acid 12 lipoxygenase (ALOX12)-ACC1 (Zhang et al., 2021). The gene discussed is ACACA; the disease is metabolic dysfunction-associated steatohepatitis.